Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,069 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.

NCT04823377

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • CH Abbeville Abbeville, France
  • CH du Pays d'Aix Aix-en-Provence, France
  • CHU Amiens - Hôpital Sud Amiens, France
  • CHU Angers Angers, France
View all 25 locations
View Trial Details
Active, Not Recruiting

Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer

NCT04940325

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Institut Bergonié Bordeaux, France
  • Institut de Cancérologie, CHRU Morvan de Brest Brest, France
  • Centre François Baclesse Caen, France
  • Centre Hospitalier Intercommunal de Créteil Créteil, France
View Trial Details
Active, Not Recruiting

A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

NCT03052608

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Florida Cancer Specialists Altamonte Springs, Florida, United States
  • Florida Cancer Specialists Brandon, Florida, United States
  • Florida Cancer Specialists Clearwater, Florida, United States
  • Florida Cancer Specialists Gainesville, Florida, United States
View all 166 locations
View Trial Details
Active, Not Recruiting

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

NCT03703297

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Santa Rosa, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Fort Myers, Florida, United States
View all 183 locations
View Trial Details
Active, Not Recruiting

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

NCT06140836

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Local Institution - 0221 Des Moines, Iowa, United States
  • Local Institution - 0075 Boston, Massachusetts, United States
  • Local Institution - 0201 Boston, Massachusetts, United States
  • Local Institution - 0210 Mineola, New York, United States
View all 122 locations
View Trial Details
Active, Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05238883

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions